CJ Bioscience, Inc. (KOSDAQ:311690)

CJ Bioscience Revenue

CJ Bioscience had revenue of 783.07M KRW in the quarter ending March 31, 2026, a decrease of -14.22%. This brings the company's revenue in the last twelve months to 3.56B, up 5.56% year-over-year. In the year 2025, CJ Bioscience had annual revenue of 3.69B with 6.52% growth.

• Revenue (ttm): 3.56B
• Revenue Growth: +5.56%
• P/S Ratio: 17.60
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 62.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.69B	225.99M	6.52%
Dec 31, 2024	3.47B	-2.11B	-37.82%
Dec 31, 2023	5.58B	1.50B	36.82%
Dec 31, 2022	4.07B	-288.37M	-6.61%
Dec 31, 2021	4.36B	-948.52M	-17.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error